¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fasting blood glucose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® white blood cell(WBC), leukocyte ÇÑ±Û ¹éÇ÷±¸
¼³¸í   
  Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, È¤Àº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀΠÇö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù.
¿µ¹® whole blood ÇÑ±Û ÀüÇ÷, ¿ÂÇ÷¾×
¼³¸í   
  Ç÷¾×ÀÇ ¸ðµç ¼ººÐÀÌ Çϳªµµ Á¦°ÅµÇÁö ¾ÊÀº ¿ÂÀüÇÑ Ç÷¾×. ÀüÇ÷Àº ¾ö°ÝÇÑ ¹«±ÕÁ¶°ÇÇÏ¿¡¼­, ¼±º°ÇÑ °øÇ÷ÀڷκÎÅ͠äÃëÇÑ °ÍÀ̸ç, ±¸¿¬»ê ÀÌ¿ÂÀ̳ª ÇìÆÄ¸° °°Àº Ç×ÀÀ°øÁ¦·Î ÀÀ°í¸¦ ¹æÁöÇÏ¿© Ç÷¾×º¸Ãæ ¸ñÀûÀ¸·Î »ç¿ëÇÑ´Ù.
¿µ¹® blood collection ÇÑ±Û Ã¤Ç÷
¼³¸í   
  1. ¸ð¼¼°üÇ÷ : Ç÷±¸¼ö-Ç÷¼ÒÆÇ¼ö °è»ê, Ç÷»ö¼Ò·®, Ç÷±¸¿ëÀûÃøÁ¤, µµ¸»Ç¥º»Á¦ÀÛ µîÀ» ÇÒ¶§ »ç¿ëµÈ´Ù. ±ÓºÒ ¶Ç´Â ¼Õ°¡¶ô³¡¹Ù´Ú¸éÀ» ÃæºÐÈ÷ ¸¶ÂûÇÑ ´ÙÀ½, ¾ËÄڿ÷Π¼Òµ¶-°ÇÁ¶½ÃÄѼ­, ÀÛÀº Ä® ¶Ç´Â Á¾µÎħ È¤Àº 1mmÀÇ ÁÖ»çħÀ¸·Î 2~3mmÀÇ ±íÀ̱îÁö Â´Ù. ¸ÇóÀ½ Çǹæ¿ïÀº ´Û¾Æ³½ ÈÄ ´ÙÀ½ Ç͹æ¿ïÀ» °Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 2. Á¤¸ÆÇ÷ : ´ë·®ÀÇ Ç÷¾×À» ¿äÇϴ °æ¿ì¿¡ »ç¿ëÇÑ´Ù. º¸Åë (ÆÈ²ÞÄ¡Á¤ÁßÇǺÎ)ÁÖÁ¤ÁßÇÇÁ¤¸ÆÀ» Â¸ç, ¿µÀ¯¾ÆÀÇ °æ¿ì¿¡´Â ¿Ü°æÁ¤¸ÆÀ» ¼±ÅÃÇϱ⵵ ÇÑ´Ù. ÁöÇ÷¿ë °í¹«ÁٷΠ»ó´ÜÀ» ÃÖÀúÇ÷¾Ð¿¡ »ó´çÇϴ Á¤µµ·Î ¹­°í, ÁÖ¸ÔÀ» ²À Áã°Ô ÇÏ¿© Á¤¸ÆÀ» ³ëÃâ½ÃŲ ÈÄ ¸ê±Õ°ÇÁ¶ÁÖ»ç±â¸¦ Ç÷°ü³»¿¡ »ðÀÔÇÑ´Ù. °ð ¹Ù·Î °í¹«ÁÙ°ú ÁÖ¸ÔÀ» Ç®°í Ã¤Ç÷À» ÇÑ ´ÙÀ½ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö´Â´Ù. 2ºÐÀÌ»óÀÇ Á¤¸Æ ¿ïÇ÷Àº Ç÷¾×¼º»ó¿¡ º¯È­¸¦ °¡Á®¿Â´Ù. 2. µ¿¸ÆÇ÷ : À§ÆÈµ¿¸Æ ¶Ç´Â ³Ò´Ù¸® µ¿¸ÆÀ» »ç¿ëÇÏ¿© ÃµÀںθ¦ ¼Òµ¶ÇÑ ´ÙÀ½, ÇÁ·ÎÄ«ÀΠ±¹¼Ò¸¶Ã븦 ÇÑ´Ù. Ã¤Ç÷ÀÚ ¿Þ¼ÕÀÇ °¡¿îµ¥¼Õ°¡¶ô°ú µÑ°¼Õ°¡¶ôÀ¸·Î µ¿¸ÆÀ» °íÁ¤Çϰí, ÁÖ»çħÀ» µ¿¸Æ¿¡ 45~65¡ÉÀÇ °¢µµ·Î Âñ·¯ ³Ö¾î Ã¤Ç÷ ÈÄ ¸öÂʵ¿¸ÆÀ» ¾öÁö¼Õ°¡¶ôÀ¸·Î ¾Ð¹ÚÇϸ鼭 ÁÖ»çħÀ» »©°í, ±× µÚ 5ºÐ°£Âë Â ºÎÀ§¸¦ ¾Ð¹ÚÇÑ´Ù.
¿µ¹® blood vessel ÇÑ±Û Ç÷°ü
¼³¸í   
  Ç÷¾×ÀÌ ´Ù´Ï´Â ±æ. µ¿¸Æ, ¸ð¼¼Ç÷°ü, Á¤¸ÆÀ¸·Î ±¸¼ºµÈ´Ù. µ¿¸ÆÀº ½ÉÀå¿¡¼­ ³ª°¡´Â ÇǸ¦ ¿î¹ÝÇϴ Ç÷°ü. À̰ÍÀº ½ÉÀå¿¡¼­ ³ª°¡´Â ÇǸ¦ ¿î¹ÝÇϴ Ç÷°üÀ̸砽ÉÀå¿¡¼­ Á÷Á¢ ¸¹Àº ¾Ð·ÂÀ» ¹Þ¾Æ¾ß ÇϹǷΠ¸¹Àº ¿¬Á¶Á÷°ú Åº¼º¼¶À¯·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. À̰ÍÀº Å©±â¿Í ±× Çö¹Ì°æÀû ±¸Á¶¿¡ µû¶ó ´ÙÀ½°ú °°ÀÌ ³ª´«´Ù. ´ëµ¿¸Æ(¿Þ½É½Ç¿¡¼­ Á÷Á¢ ³ª¿À´Â µ¿¸Æ. ¿Â¸öÀÇ Ç÷¾× ¼øÈ¯ÀÇ Áٱ⿪ÇÒÀ» ÇÑ´Ù), µ¿¸Æ(´ëµ¿¸Æ¿¡¼­ ºÐÁö¸¦ ³½ Áß°£ Å©±âÀÇ µ¿¸Æ), ¼¼µ¿¸Æ(µ¿¸Æ¿¡¼­ ºÐÁö¸¦ ³½ ÀÛÀº µ¿¸ÆÀ» ¸»ÇÑ´Ù)À¸·Î ³ª´«´Ù.
  
  ¸ð¼¼Ç÷°ü(capillary)Àº ÇÑÃþÀÇ ¼¼Æ÷·Î ÀÌ·ç¾îÁø ¾ãÀº Ç÷°ü. À̰ÍÀ» ÅëÇØ¼­ ¿µ¾çºÐ°ú »ê¼ÒÀÇ À̵¿, ³ëÆó¹°ÀÇ À̵¿ µîÀÌ ÀÌ·ç¾îÁø´Ù.
  
  Á¤¸Æ(vein)Àº ½ÉÀåÀ¸·Î µé¾î¿À´Â Çǰ¡ È帣´Â Åë·Î. µ¿¸Æ¿¡ ºñÇØ¼­ Ç÷°üÀÇ º®ÀÌ ¾ã°í Ç÷¾×ÀÇ ¿ª·ù¸¦ ¹æÁöÇϱâ À§ÇÑ ÆÇ¸·ÀÌ Á¸ÀçÇϴ °ÍÀ̠Ư¡ÀÌ´Ù. À̰ÍÀº ½ÉÀå¿¡¼­ Á÷Á¢ ¾Ð·ÂÀ» ¹ÞÁö ¾Ê±â¶§¹®¿¡ Ç÷¾×ÀÌ ¿ª·ùÇÒ ¼öµµ ÀÖ°í ¶Ç Ç÷°üº®ÀÌ ¾ã¾Æµµ µÇ±â ¶§¹®ÀÌ´Ù. Å©±â¿Í Çö¹Ì°æÀû ±¸Á¶¿¡ µû¶ó ´ëÁ¤¸Æ(½ÉÀå°ú Á÷Á¢ ¿¬°áµÇ´Â Á¤¸Æ), Á¤¸Æ(´ëÁ¤¸Æ¿¡ À̸£±âÀü Áß°£ ±½±âÀÇ Á¤¸Æ), ¼¼Á¤¸Æ(¸ð¼¼Ç÷°ü°ú Á÷Á¢ ¿¬°áµÇ¾î Àִ ÀÛÀº ±½±âÀÇ Á¤¸Æ)À¸·Î ³ª´«´Ù.
  
  Ç÷°ü
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin-to-glucose ratio
    Àν¶¸°´ëÆ÷µµ´çºñ
  • liquid glucose
    ¾×üÆ÷µµ´ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´ç³»¼º°Ë»ç
  • urine glucose
    ¿ä´ç
  • arterial blood
    µ¿¸ÆÇ÷¾×, µ¿¸ÆÇÇ
  • arterial blood gas
    µ¿¸ÆÇ÷°¡½º
  • arterial blood gas analysis
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • artificial blood
    ÀΰøÇ÷¾×
  • autologous blood
    ÀÚ°¡Ç÷¾×
  • automated noninvasive blood pressure device
    ºñħ½ÀÀÚµ¿Ç÷¾Ð±â
  • ABO blood group system
    ABOÇ÷¾×Çüü°è
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®, Çã¿ëÇ÷¾×»ó½Ç·®
  • blood
    Ç÷¾×, ÇÇ
  • blood agar
    Ç÷¾×¿ì¹«¹èÁö
  • blood agar medium
    Ç÷¾×¿ì¹«¹èÁö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • venous blood
    Á¤¸ÆÇ÷¾×, Á¤¸ÆÇÇ
  • whole blood
    ÀüÇ÷, ¿ÂÇ÷¾×
  • blood concentration
    Ç÷Áß³óµµ
  • blood collection
    äÇ÷
  • blood cell
    Ç÷¾×¼¼Æ÷, Ç÷±¸
  • blood count
    Ç÷±¸°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • packed red blood cell
    ³óÃàÀûÇ÷±¸
  • red blood cell
    ÀûÇ÷±¸
  • red blood corpuscle
    ÀûÇ÷±¸
  • white blood corpuscle
    ¹éÇ÷±¸
  • blood donor
    ÇåÇ÷ÀÚ, °øÇ÷ÀÚ
  • blood donation
    ÇåÇ÷
  • blood film examination
    Ç÷¾×Æì¹Ù¸¥°Ë»ç, Ç÷¾×µµ¸»°Ë»ç
  • blood film
    Ç÷¾×Æì¹Ù¸¥Ç¥º», Ç÷¾×µµ¸»
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin-to-glucose ratio
    Àν¶¸°Æ÷µµ´çºñÀ²
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • ABO blood group system
    ¿¡À̺ñ¿ÀÇ÷¾×Çü±º
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®
  • arterial blood
    µ¿¸ÆÇ÷¾×, µ¿¸ÆÇÇ
  • arterial blood gas study
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • artificial blood
    ÀΰøÇ÷¾×
  • autologous blood
    ÀÚ°¡Ç÷¾×
  • automated noninvasive blood pressure device
    ºñħ½ÀÀÚµ¿Ç÷¾Ð±â
  • blood gas apparatus
    Ç÷¾×°¡½ººÐ¼®ÀåÄ¡
  • soybean-casein digest blood agar
    ¼ÒÀ̺óÄ«Á¦ÀμÒÈ­Ç÷¾×¿ì¹«
  • blood
    Ç÷¾×, ÇÇ
  • bank blood
    ÀúÀåÇ÷¾×
  • basal blood pressure
    ±âÀúÇ÷¾Ð
  • blood bank
    Ç÷¾×ÀºÇà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucose 6 phosphate dehydrogenase =G 6 PD
    ±Û·çÄÚ¿À½º 6Àλê Å»¼ö ¼ÒÈ¿¼Ò, ±Û·çÄÚ¿À½º-6-ÀÎ»ê µ¥È÷µå·Î°Ô³ªÁ¦.
  • glucose 6 phosphate dehydrogenase def
    ±Û·çÄÚ¿À½º-6-Àλê Å»¼ö¼Ò È¿¼Ò°á
  • glucose dehydrogenase
    ±Û·çÄÚ¿À½ºÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çÄÚ¿À½ºµ¥È÷µå·Î°Ô³ªÁ¦.
  • glucose effect
    Æ÷µµ´çÈ¿°ú
  • glucose equivalent
    ±Û·çÄÚ¿À½º´ç·®.
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿¼Ò
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose insulin tolerance test =GITT
    Æ÷µµ´çÀν¶¸°ºÎÇϽÃÇè.
  • glucose intolerance
    Æ÷µµ´ç ºÒ³»¼º
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»ê ȸ·Î.
  • glucose level
    Æ÷µµ´çÄ¡<--ÁØÀ§>
  • glucose measurement
    Æ÷µµ´çÃøÁ¤
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • glucose oxidase
    Æ÷µµ´ç»êÈ­È¿¼Ò
  • glucose oxidase =GOD
    ±Û·çÄÚ¿À½º »êÈ­È¿¼Ò(¡­ß«ûùý£áÈ), ±Û·çÄÚ¿À½º¿Á½Ã ´ÙÁ¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucose 3 phosphatase =G-3-P
    ±Û·çÄÚ¿À½º-3-Æ÷½ºÆÄŸÁ¦.
  • glucose 6 phosphatase =G-6-P
    ±Û·çÄÚ¿À½º-6-Æ÷½ºÆÄŸÁ¦.
  • glucose 6 phosphatase deficiency hepa
    ±Û·çÄÚ¿À½º-6 -ÀÎ»ê °áÇ̰£½ÅÇü´ç
  • glucose 6 phosphate
    ±Û·çÄÚ¿À½º-6-Àλê.
  • glucose 6 phosphate dehydrogenase =G 6 PD
    ±Û·çÄÚ¿À½º 6Àλê Å»¼ö ¼ÒÈ¿¼Ò, ±Û·çÄÚ¿À½º-6-ÀÎ»ê µ¥È÷µå·Î°Ô³ªÁ¦.
  • glucose 6 phosphate dehydrogenase def
    ±Û·çÄÚ¿À½º-6-Àλê Å»¼ö¼Ò È¿¼Ò°á
  • glucose dehydrogenase
    ±Û·çÄÚ¿À½ºÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çÄÚ¿À½ºµ¥È÷µå·Î°Ô³ªÁ¦.
  • glucose effect
    Æ÷µµ´çÈ¿°ú
  • glucose equivalent
    ±Û·çÄÚ¿À½º´ç·®.
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿¼Ò
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose insulin tolerance test =GITT
    Æ÷µµ´çÀν¶¸°ºÎÇϽÃÇè.
  • glucose intolerance
    Æ÷µµ´ç ºÒ³»¼º
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»ê ȸ·Î.
  • glucose level
    Æ÷µµ´çÄ¡<--ÁØÀ§>
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Blood cells
    Ç÷¾×¼¼Æ÷ [Ç÷±¸]
    [¿¾ ¿ë¾î] Ç÷¾×¼¼Æ÷
  • Blood
    Ç÷¾× (ÇÇ)
    [¿¾ ¿ë¾î] Ç÷¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adenosine diphosphate glucose
    ÀÌÀλê(ì£ìÝß«)¾Æµ¥³ë½Å ±Û·çÄÚ½º
  • ADP-glucose
    ADP-±Û·çÄÚ½º
  • glucose
    ±Û·çÄÚ½º
  • glucose-alanine cycle
    ±Û·çÄÚ½º-¾Ë¶ó´Ñ ȸ·Î(üÞÖØ)
  • glucose effect
    ±Û·çÄÚ½º È¿°ú(üùÍý)
  • glucose electrode
    ±Û·çÄÚ½º Àü±Ø(ï³Ð¿)
  • glucose-6-phosphatase
    ±Û·çÄÚ½º-6-Æ÷½ºÆÄÅ×À̽º
  • glucose-6-phosphate
    ±Û·çÄÚ½º-6-Àλê(×òß«)
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º °áÇÌ(ÌÀ
  • glucose-regulated protein
    ±Û·çÄÚ½º-Á¶Àý (ðàï½) ´Ü¹éÁú(Ó±ÛÜòõ)
  • glucose repression
    ±Û·çÄÚ½º ¾ïÁ¦(åäð¤)
  • glucose tolerance factor
    ±Û·çÄÚ½º ³»¼º ÀÎÀÚ(Ò±àõì×í­)
  • glucose tolerance test
    ±Û·çÄÚ½º ³»¼º °Ë»ç(Ò±àõì×í­)
  • UDP-glucose
    UDP-±Û·çÄÚ½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood sugar
    Ç÷´ç
  • blood supply
    Ç÷¾×°ø±Þ
  • blood vessel
    Ç÷°ü, ÇÍÁÙ
  • blood volume
    Ç÷¾×¾ç
  • BOLD [=blood oxygenation level dependent]
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸
  • bright blood imaging
    ¸íÇ÷·ù¿µ»ó
  • cord blood
    Á¦´ëÇ÷¾×
  • electromagnetic blood flowmeter
    ÀüÀÚ±âÇ÷·ùÃøÁ¤±â
  • fat blood level
    Áö¹æÇ÷Ãþ
  • liver blood flow
    °£ÀåÇ÷¾×À¯Åë, °£Ç÷·ù
  • maximal blood pressure
    ÃÖ´ëÇ÷¾Ð, ÃÖ°íÇ÷¾Ð
  • occult blood
    ÀáÇ÷
  • portal blood pressure
    ¹®¸Æ¾Ð
  • red blood cell
    ÀûÇ÷±¸
  • systemic blood pressure
    üÇ÷¾Ð
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FSG fasting serum glucose; focal segmental sclerosis
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
FBS Fasting Blood Sugar; °øº¹½Ã Ç÷´ç
BFS blood fasting sugar
FB fasting blood [sugar]; feedback; fiberoptic bronchoscopy; fingerbreadth; foreign body; Fusobacterium...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FHP Fasting heat production
FIRI Fasting insulin resistance index
FPI Fasting plasma insulin
glucose 6-P glucose 6-phosphate
BG Blood Glucose
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blood
    ÇÇ, Ç÷¾×
    1. ¸Æ°ü°è¸¦ È帣°í ÀÖ´Â ¾×ü·Î ¼¼Æ÷ ¼ººÐÀÎ Ç÷±¸¿Í Ç÷ûÀ¸·Î ±¸¼ºµÈ´Ù. ½ÉÀå ¹× Ç÷°ü Áï ¼øÈ¯°è¸¦ ä¿ì°í ÀÖ´Â ¾×üÀÌ´Ù. 2. ÇÇ, ½ÉÀå, µ¿¸Æ, ¸ð¼¼Ç÷°ü ¹× Á¤¸Æ³»¸¦ ¼øÈ¯Çϸ鼭 ½Åü³» ¼¼Æ÷¿¡ ¿µ¾çºÐ°ú »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â ¾×üÀ̸ç, ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇ µîÀ» Æ÷ÇÔÇÑ À¯Çü ¼ººÐ°ú Ç÷ÀåÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. 3. ²öÀû²öÀûÇÑ ¾×ü·Î¼­, ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò ?¹®¿¡ ¼±È«»öÀ» ¶è´Ù. 4. Ç÷°ü ¼ÓÀ» È帣°í ÀÖ´Â ¾×»óÀÇ Á¶Á÷. ¼±¸íÇÑ Àû»öÀ» ¶ì°í ÀÖ°í ºÒÅõ¸íÇÏ¸ç ±ÕÀÏÇÏ°Ô º¸ÀδÙ. ±×·¯³ª Ç÷¾×ÀÇ ÀÛÀº ¹æ¿ïÀ» À¯¸®ÆÇ¿¡ ¾ã°Ô Æì°í Çö¹Ì°æÀ¸·Î º¸¸é Åõ¸íÇÑ ¾×ü ¼Ó¿¡ Ç÷±¸°¡ ºÎÀ¯Çϰí ÀÖ¾î ±ÕÀÏÇÏÁö ¾ÊÀ½À» ¾Ë ¼ö ÀÖ´Ù. Ç÷¾×ÀÇ ÁÖµÈ ¿ªÇÒÀº °¢Á¾ ¹°ÁúÀÇ ¿î¹ÝÀ̸ç, Æó¿¡¼­ ¼·ÃëÇÑ »ê¼Ò³ª ¼ÒÈ­°ü¿¡¼­ Èí¼öÇÑ ¿µ¾ç¼Ò µîÀ» Àü½ÅÀÇ ¸ðµç ¼¼Æ÷·Î º¸³»°í ¹Ý´ë·Î ¼¼Æ÷¿¡¼­ ¸¸µé¾îÁø ź»ê°¡½º³ª ³ëÆó¹°À» ¿î¹ÝÇØ¼­ Æó, ½ÅÀå, ÇǺΠµîÀ» ÅëÇØ¼­ ¸ö¹ÛÀ¸·Î ¹è¼³ÇÑ´Ù. ¶Ç °ñ°Ý±ÙÀ̳ª °£°ú °°ÀÌ ¿­ »ý»êÀÌ ¿Õ¼ºÇÑ °÷À¸·ÎºÎÅÍ ´Ù¸¥ ºÎºÐÀ¸·Î ¿­À» ¿Å°Ü¼­ ü¿­ÀÇ ºÐÆ÷¸¦ ±ÕµîÇÏ°Ô Çϰí, ÇǺο¡¼­ ¹æ¿­ÇÏ¿© ü¿ÂÀ» ÀÏÁ¤ÇÏ°Ô À¯Áö½ÃŰ´Â µ¥µµ °ü¿©ÇÑ´Ù. Ç÷¾×·®Àº üÁßÀÇ ¾à 8 %, ºñÁßÀº 1.06À̹ǷΠüÁßÀÌ 60 kgÀÎ ¶§ ¾à 4.5§¤°¡ µÈ´Ù. Ç÷¾×·®Àº °ÅÀÇ ÀÏÁ¤Çؼ­ ¾×ü¸¦ ¼·ÃëÇßÀ» ¶§³ª ÀûÀº ¾çÀÇ ÃâÇ÷ÀÌ ÀÖÀ» ¶§µµ Ç÷°ü ¼ÓÀÇ ¼øÈ¯ Ç÷¾×·®À» ÀÚÀ²ÀûÀ¸·Î Á¶ÀýÇÏ¿© Àüü Ç÷¾×·®Àº º¯ÇÏÁö ¾Ê´Â´Ù. ÇÑÆí, ´ë·®ÀÇ ¹°À» ¸¶¼ÌÀ» ¶§ ¼öºÐÀº °ð Ç÷¾×¿¡¼­ Á¶Á÷À¸·Î ³ª°¡°Å³ª ½ÅÀåÀ¸·ÎºÎÅÍ ¹è¼³µÈ´Ù. Ç÷¾×ÀÇ Á¡Á¶µµ´Â ¹°ÀÇ ¾à 5¹èÀ̰í, ÁÖ·Î Ç÷±¸ ¼ö¿¡ µû¶ó º¯ÇÑ´Ù. ºóÇ÷ÀÏ ¶§Ã³·³ ÀûÇ÷±¸°¡ °¨¼ÒÇϸé Á¡Á¶µµ°¡ ³·¾ÆÁ®¼­ Ç÷¾×ÀÌ Ç÷°ü ³»¸¦ È带 ¶§ ÀúÇ×ÀÌ °¨¼ÒµÇ¹Ç·Î Ç÷¾ÐÀÌ ¶³¾îÁø´Ù. µû¶ó¼­ Ç÷¾×ÀÇ Á¡Á¶µµ°¡ Ç÷¾ÐÀ» À¯ÁöÇÏ´Â µ¥¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϰí ÀÖÀ½À» ¾Ë ¼ö ÀÖ´Ù. Ç÷¾×ÀÇ »ïÅõ¾ÐÀº 6.7±â¾ÐÀ¸·Î 0.9 %ÀÇ ½Ä¿°¼ö¿Í °°´Ù. ¸¸¾à Ç÷¾×º¸´Ù ³·Àº »ïÅõ¾ÐÀÇ ½Ä¿°¼ö¿¡ Ç÷¾×À» ³ÖÀ¸¸é Ç÷±¸ ¼Ó¿¡ ¼öºÐÀÌ »¡·Á µé¾î°¡ ºÎÇ®¾î ¸¶Ä§³»´Â ÆÄ±«µÈ´Ù. À̰ÍÀ» ¿ëÇ÷À̶ó°í ÇÑ´Ù. ¶Ç ¹Ý´ë·Î Ç÷¾×º¸´Ù ³ôÀº »ïÅõ¾ÐÀÇ ½Ä¿°¼ö ¾È¿¡¼­´Â Ç÷±¸ ¼ÓÀÇ ¼öºÐÀÌ ¹ÛÀ¸·Î ³ª¿Í Ç÷±¸´Â ¿À±×¶óµé°í ¸¸´Ù. ±×¸®°í Ç÷¾×°ú °°Àº »ïÅõ¾ÐÀÇ ½Ä¿°¼ö¸¦ »ý¸®Àû ½Ä¿°¼ö¶ó ÇÑ´Ù. Ç÷¾×ÀÇ
  • blood agar
    Ç÷¾× ÇÑõ
  • blood alcohol level
    Ç÷Áß ¾ËÄÚ¿Ã ³óµµ
  • blood blister
    ¼ÒÇ÷Á¾
    Ç÷¾×¼º ³»¿ë¹°À» °¡Áø ÀÛÀº ¼öÆ÷·Î¼­ ²¿ÁýÈ÷°Å³ª Ÿ¹Ú»óÀ¸·Î »ý±âÁö¸¸ °¡²û Áö¼ÓÀûÀÎ ¸¶Âû¿¡ ÀÇÇØ¼­µµ »ý±ä´Ù.
  • blood capillary
    ¸ð¼¼Ç÷°ü
    ¼Òµ¿¸Æ°ú ¼ÒÁ¤¸ÆÀ» ¿¬°áÇÏ´Â ¹Ì¼¼ÇÑ Ç÷°ü. ÀÌ º®Àº Ç÷¾×°ú Á¶Á÷¾×ÀÇ ¿©·Á ¹°ÁúÀ» ±³È¯Çϱâ À§ÇÑ ¹ÝÅõ¸·À¸·Î ÀÛ¿ëÇÑ´Ù.
  • blood cell counter
    Ç÷±¸ °è¼ö±â
  • blood center
    Ç÷¾×¿ø
    µ¿ÀǾî=blood transfusion service. ¼öÇ÷¿¡ ÇÊ¿äÇÑ Ç÷¾×À» äÇ÷, Á¶Á¦, º¸Á¸ÇÏ°í °ø±ÞÇÏ´Â ±â°ü. 1937³â ¹Ì±¹ ½ÃÄ«°íÀÇ ÄîÄ«¿îƼ
  • blood cerebrospinal fluid barrier
    Ç÷³ú ô¼ö¾× À庮, Ç÷¾× ³úô¼ö¾× °ü¹®
  • blood circulation
    Ç÷¾× ¼øÈ¯
    Á½ɽǿ¡¼­ µ¿¸ÆÀ¸·Î ¾ÐÃâµÈ Ç÷¾×Àº ¸ð¼¼Ç÷°üÀ» °ÅÃļ­ Á¤¸ÆÀ¸·Î ³ª¿À°í ¿ì½É¹æÀ¸·Î ȯ·ùÇØ À̰÷¿¡¼­ ¿ì½É½Ç·Î µé¾î°£´Ù. ¿ì½É½ÇÀÇ ¼öÃàÀ¸·Î Æóµ¿¸ÆÀ¸·Î º¸³»Á® Æó ¸ð¼¼°üÀ» °ÅÃļ­ Æó Á¤¸Æ¿¡¼­ Á½ɹæÀ¸·Î µé¾î°¡°í ´Ù½Ã Á½ɽǷΠµé¾î°¡ ¸ö ¾ÈÀ» ÇѹÙÄû µ·´Ù.
  • blood clotting disturbance
    Ç÷¾× ÀÀ°í Àå¾Ö
  • blood coagulation
    Ç÷¾× ÀÀ°í
    µ¿ÀǾî=blood clotting. 1. Ç÷¾×ÀÇ ¸¹Àº ÀÀ°íÀÎÀÚ°¡ »óÈ£ÀÛ¿ëÇϰí ÇÕÃÄÁ®¼­ ÃÖÈÄ¿¡´Â ºÒ¿ë¼ºÀÇ ¼¶À¯¼Ò ±«ÀÇ Çü¼ºÀ» ÀÏÀ¸Å°´Â ¿¬¼ÓÀû ¹ÝÀÀÀÌ´Ù. 2. Ç÷¾×ÀÌ Ç÷°ü ¹ÛÀ¸·Î ³ª¿ÔÀ» ¶§ Á©¸®»óÀ¸·Î ±»¾îÁö´Â Çö»ó. À̰ÍÀº Ç÷¾× ¼Ó¿¡ ÇǺ기À̶ó°í ÇÏ´Â ½Ç ¸ð¾çÀÇ ¹°ÁúÀÌ ¼®ÃâµÇ¾î ±×¹° ¸ð¾çÀ¸·Î ¾ôÈ÷°í, ±× ¼Ó¿¡ Ç÷±¸¸¦ °¡µÎ¾î µÎ±â ¶§¹®ÀÌ´Ù. ÀÌ Ç÷±¸ µ¢¾î¸®´Â ½Ã°£ÀÌ Áö³²¿¡ µû¶ó Á¡Á¡ ¼öÃàÇÏ¿© ÀÛ¾ÆÁö¸é¼­ ´ãȲ»öÀÇ Åõ¸íÇÑ ¾×ü°¡ ½º¸ç ³ª¿Â´Ù. Ç÷±¸ÀÇ µ¢¾î¸®¸¦ Ç÷º´À̶ó Çϰí, ½º¸ç ³ª¿Â Åõ¸íÇÑ ¾×ü¸¦ Ç÷ûÀ̶ó°í ÇÑ´Ù. Ç÷¾× ÀÀ°í´Â »ý¸íÀ» À¯ÁöÇÏ´Â µ¥ ºÒ°¡°áÇÑ °ÍÀ¸·Î, ¸¸ÀÏ Ç÷¾×¿¡ ÀÌ ÀÛ¿ëÀÌ ¾øÀ¸¸é ÃâÇ÷¿¡ ÀÇÇÏ¿© °ð Á×°Ô µÈ´Ù. ÀÏ»ó»ýȰ¿¡¼­´Â ²÷ÀÓ¾øÀÌ ¿Ü»óÀ» ÀÔ°Ô µÇ°í ±×¶§ ´Ù¼Ò³ª¸¶ ¸ð¼¼Ç÷°üÀÌ ÆÄ¿­µÇ´Âµ¥, ÆÄ¼ÕºÎÀ§´Â Ç÷¾× ÀÀ°í¿¡ ÀÇÇÏ¿© ¼öº¹µÈ´Ù. Ç÷¾× ÀÀ°í°¡ ÀϾ´Â ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼­´Â ¸î °¡Áö ¼³ÀÌ ÀÖÁö¸¸ ¾î´À °ÍÀÌµç ±âº»ÀûÀ¸·Î´Â Ç÷¾×ÀÌ Ç÷°ü ¹ÛÀ¸·Î ³ª¿À¸é Ç÷¼ÒÆÇÀÌ ÆÄ±«µÇ¾î Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ »ý±â°í, À̰ÍÀÌ Ç÷¾× ¼ÓÀÇ Ä®½· À̿°ú ÇÔ²² ÀÛ¿ëÇÏ¿© Ç÷Àå ´Ü¹éÁúÀÇ ÇϳªÀÎ ÇÁ·ÎÆ®·ÒºóÀ» Æ®·ÒºóÀ¸·Î º¯È­½ÃŲ´Ù. ÀÌ Æ®·ÒºóÀÌ ÇǺ긮³ë°Õ¿¡ ÀÛ¿ëÇÏ¿© ÇǺ기ÀÌ µÈ´Ù. ÀÌ °úÁ¤¿¡´Â Ç÷ÀåÀ̳ª Ç÷¼ÒÆÇ¿¡ ÀÖ´Â ¸¹Àº ÀÎÀÚ°¡ °ü¿©Çϴµ¥, ¿¬±¸ÀÚ¿¡ µû¶ó °¢¾ç°¢»öÀÇ À̸§À¸·Î ºÒ¸®¾î È¥¶õÀ» ÃÊ·¡Çϰí ÀÖÀ¸¹Ç·Î, ±¹Á¦Ç÷¾×ÀÀ°íÀ§¿øÈ¸¿¡¼­ À̵é ÀÎÀÚ¸¦ ¹øÈ£·Î ³ªÅ¸³»µµ·Ï °áÁ¤Çϰí ÀÖ´Ù. Á¦1»óÀÇ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ Çü¼ºµÇ´Â °úÁ¤ÀÌ °¡Àå º¹ÀâÇϰí, Ç÷¾× ÀÀ°í¿¡ °É¸®´Â ´ëºÎºÐÀÇ ½Ã°£ÀÌ ÀÌ °úÁ¤¿¡ ¼Ò¿äµÈ´Ù. Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ ¸¸µé¾îÁö´Â µ¥´Â µÎ °¡Áö °æ·Î°¡ ÀÖ´Ù. óÀ½ °æ·Î´Â Ç÷°ü ¼Ó¿¡¼­ ÀÌ·ç¾îÁø´Ù. Ç÷Àå ¼Ó¿¡ À̹°Áú°ú Á¢Çϸé Ȱ¼ºÈ­µÇ´Â È¿¼Ò°¡ Àִµ¥, ÇöÀç Á¦ XIÀÎÀÚ¿Í Á¦ XIIÀÎÀÚÀÇ µÎ °¡Áö°¡ ¾Ë·ÁÁ® ÀÖ´Ù. À̰ÍÀÌ ¹æ¾Æ¼è°¡ µÇ¾î Á¦ VÀÎÀÚ, Á¦ VIIIÀÎÀÚ, Á¦ IXÀÎÀÚ µî°ú Ç÷¼ÒÆÇÀ¸·ÎºÎÅÍÀÇ ÀÎÀÚ°¡ ÀÛ¿ëÇÏ¿© Ç÷¾× Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ »ý¼ºµÈ´Ù. ´Ù¸¥ ÇϳªÀÇ °æ·Î´Â Ç÷°ü ¹ÛÀÇ Á¶Á÷¿¡¼­ ÀÌ·ç¾îÁø´Ù. ÆÄ±«µÈ Á¶Á÷¿¡ Ç÷Àå ¼ÓÀÇ Á¦ VÀÎÀÚ, Á¦ VIIÀÎÀÚ, Á¦ XÀÎÀÚ µîÀÌ ÀÛ¿ëÇÏ¿© Á¶Á÷ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ »ý¼ºµÈ´Ù. Á¦2»óÀÇ Æ®·ÒºóÀÇ »ý¼º¿¡¼­´Â Ç÷¾× ¹× Á¶Á÷¿¡ »ý±ä Ȱ¼º Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ Ä®½· À̿°ú ÇÔ²² Ç÷Àå ¼ÓÀÇ ÇÁ·ÎÆ®·Òºó¿¡ ÀÛ¿ëÇÏ¿© Æ®·ÒºóÀ» Çü¼ºÇÑ´Ù. ÇÁ·ÎÆ®·ÒºóÀº °£¿¡¼­ ºñŸ¹Î KÀÇ ÀÛ¿ëÇÏ¿¡ ¸¸µé¾îÁö°í, ÇìÆÄ¸°Àº ÀÌ Á¦ 2»óÀ» ¾ïÁ¦ÇÏ¿© Ç÷¾× ÀÀ°í ÀúÁö ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. Á¦ 3»ó¿¡¼­´Â Æ®·ÒºóÀÌ ÇǺ긮³ë°ÕÀÇ ÆéƼµå °áÇÕÀ» ºÐÇØÇÏ¿© ÇǺ기 ¼¶À¯¸¦ ¼®Ãâ½ÃŲ´Ù. ¿©±â¿¡ Ä®½· À̿°ú ÇÔ²² Á¦ XIII ÀÎÀÚ°¡ ÀÛ¿ëÇÏ¿© ÇǺ기¸ÁÀ» ¸¸µé¾î Ç÷º´ÀÌ ¿Ï¼ºµÈ´Ù. ¿©±â¿¡¼­ »ý¼ºµÈ ÇǺ기Àº ±×´ë·Î µÎ¸é ´Ù½Ã ¿ëÇØµÇ´Âµ¥ À̰ÍÀ» ¼¶À¯¼Ò ¿ëÇØ¶ó°í ÇÑ´Ù. ÀÌ ¼¶À¯¼Ò ¿ëÇØ´Â Ç÷Àå ¼Ó¿¡ ÀÖ´Â Çö󽺹̳ë°ÕÀÌ È°¼ºÈ­ÇÏ¿© Çö󽺹ÎÀÌ µÇ°í ÇǺ기À» ³ìÀ̱⠶§¹®ÀÌ´Ù.
  • blood compatibility testing
    Ç÷¾× ÀûÇÕ¼º °Ë»ç
  • blood concentration
    Ç÷Áß ³óµµ
  • blood count
    Ç÷±¸°è»ê
    ÀÏÁ¤ÀÇ Ç÷¾×·® 1§§Áß À¯Çü ¼ººÐ¼öÀÇ ÃøÁ¤.
  • blood culture
    Ç÷¾× ¹è¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
glucose-1-phosphatase <enzyme> Catalyses the conversion of d-glucose 1-phosphate and water to d-glucose and orthophosphate
Registry number: EC 3.1.3.10
Synonym: agp gene product
(26 Jun 1999)
glucose 1-phosphate <biochemistry> Product of glycogen breakdown by phosphorylase. Converted to glucose 6 phosphate by phosphoglucomutase.
(18 Nov 1997)
glucose-1-phosphate adenylyltransferase <enzyme> Shrunken-2 (sh2) protein is a subunit of this enzyme
Registry number: EC 2.7.7.27
Synonym: adpg synthetase, adpglucose pyrophosphorylase, ADP-glucose synthetase, shrunken-2 protein, shrunken gene product, ADP-glucose pyrophosphorylase, glgc gene product, bt2 gene product, brittle-2 gene product
(26 Jun 1999)
glucose-1-phosphate kinase <enzyme> An enzyme that, in the presence of ATP, catalyses the phosphorylation of d-glucose 1-phosphate to form d-glucose 1,6-bisphosphate and ADP; found in yeast and muscle; d-glucose 1,6-bisphosphate is a required cofactor of one of the enzymes in glycogenolysis.
Synonym: glucose-1-phosphate kinase.
(05 Mar 2000)
glucose-1-phosphate phosphodismutase A phosphotransferase catalyzing the reversible transfer of a phosphate residue from one d-glucose 1-phosphate to another, yielding d-glucose 1,6-bisphosphate and d-glucose. This enzyme provides a crucial intermediate needed for glucose-phosphate isomerase.
(05 Mar 2000)
glucose-1-phosphate uridylyltransferase <enzyme> An enzyme that activates d-glucose by reacting d-glucose 1-phosphate with UTP, producing pyrophosphate and UDP glucose; a crucial step in glycogen biosynthesis.
(05 Mar 2000)
glucose-1-phospho-D-mannosylglycoprotein phosphodiesterase <enzyme> Removes the glucose-1-phosphate from glc-alpha-1-p-6-mannose residues in glycoproteins as a unit; pH optimum 7.5
Registry number: EC 3.1.4.51
Synonym: ag1p phosphodiesterase, alpha-glucose-1-phosphate phosphodiesterase
(26 Jun 1999)
glucose-3-phosphatase <enzyme> From rat liver; has glucose-3-phosphate hydrolytic activity
Registry number: EC 3.1.3.-
(26 Jun 1999)
glucose-6-dehydrogenase deficiency <biochemistry> An inherited condition that results in a deficiency in glucose-6-phosphate dehydrogenase. Particular drugs (sulphonamides) can exacerbate this problem. The result is haemolytic anaemia.
(27 Sep 1997)
glucose-6-phosphatase <enzyme> An enzyme that catalyses the conversion of d-glucose-6-phosphate and water to d-glucose and orthophosphate. This enzyme is deficient in glycogen storage disease Ia.
Chemical name: D-Glucose-6-phosphate phosphohydrolase
Registry number: EC 3.1.3.9
(12 Dec 1998)
glucose-6-phosphatase hepatorenal glycogenosis Glycogenosis due to glucose-6-phosphatase deficiency, resulting in accumulation of excessive amounts of glycogen of normal chemical structure, particularly in liver and kidney.
Synonym: Gierke's disease, glucose-6-phosphatase hepatorenal glycogenosis, von Gierke's disease.
(05 Mar 2000)
glucose-6-phosphate <biochemistry> Glucose 6-phosphate is a phosphomonoester of glucose that is formed by transfer of phosphate from ATP, catalysed by the enzyme hexokinase.
It is an intermediate both of the glycolytic pathway (next converted to fructose 6 phosphate) and of the NADPH generating pentose phosphate pathway, formed from glucose via hexokinase. However it is not strictly a glycolytic intermediate and it is readily converted to glycogen or oxidized to NADPH.
(10 Oct 1997)
glucose-6-phosphate dehydrogenase <enzyme> An NADP+ enzyme that catalyses the dehydrogenation (oxidation) of d-glucose-6-phosphate to 6-phospho-d-glucono-d-lactone, this reaction initiating the Dickens shunt.
Deficiency of this enzyme is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people.
The gene for this enzyme is on the X chromosome. Males with the enzyme deficiency develop haemolytic anaemia when red blood cells are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans.
Synonym: Robison ester dehydrogenase, Zwischenferment.
Acronym: G6PD
(12 Sep 2002)
glucose-6-phosphate dehydrogenase deficiency A deficiency of glucose-6-phosphate dehydrogenase, an enzyme important for maintaining cellular concentrations of reduced nucleotides.
Deficiency of this enzyme is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people.
The gene for this enzyme is on the X chromosome and there are various polymorphic forms.
Males with the enzyme deficiency develop haemolytic anaemia when red blood cells are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans. It can also cause anaemia of the newborn, and chronic nonspherocytic haemolytic anaemia.
Inheritance: X-linked.
(12 Sep 2002)
glucose-6-phosphate isomerase <enzyme> An enzyme that catalyses the reversible interconversion of glucose-6-phosphate and fructose-6-phosphate, and is a part of the glycolytic and gluconeogenic pathways. Deficiency of the enzyme, an autosomal recessive trait, results in liver glycogenesis and haemolytic anaemia.
Chemical name: D-Glucose-6-phosphate ketol-isomerase
Registry number: EC 5.3.1.9
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood money
    »ìÀλç·Ê±Ý;(Àû±â¸¦ °ÝÃßÇÑ ÀÚ¿¡°Ô ÁÖ´Â)°ø·Î±Ý;À§ÀÚ·á
  • blood poisoning
    ÆÐÇ÷Áõ
  • blood pressure
    Ç÷¾Ð
  • blood relation
    Ç÷Á·
  • blood royal
    ¿ÕÁ·
  • blood test
    Ç÷¾×°Ë»ç
  • blood transgusion
    ¼öÇ÷¹ý !
  • blood vessel
    Ç÷°ü öÇ
  • blue blood
    ¸í¹®(ÇǺΰ¡ Èñ°í Á¤¸ÆÀÌ ºñÃÄ º¸ÀÌ´Â µ¥¼­);±ÍÁ·
  • dragon's blood
    ±â¸°Ç÷(¿ëÇ÷¼ö)ÀÇ ¿­¸Å¿¡¼­ äÃëÇÑ ¼öÁö;¿Í´Ï½º µîÀÇ Âø»öÁ¦)
  • first blood
    ÃÖÃÊ·Î ÃâÇ÷½Ã۱â;ÃʹÝÀÇ ¿ì¼¼
  • full blood
    ¼øÁ¾ÀÇ »ç¶÷
  • half blood
    À̺¹,¹è(´Ù¸¥)°ü°è
  • half blood
    ¹è´Ù¸¥;¾¾´Ù¸¥
  • half blood
    (ÇüÁ¦,ÀڸŰ¡)¹è(¾¾)°¡ ´Ù¸§;¹è(¾¾) ´Ù¸¥ ÇüÁ¦(ÀÚ¸Å)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á